Massachusetts General Hospital

BiographyKathleen E Corey, MD, MPH is an Instructor in Medicine at Harvard Medical School and Director of the MGH Fatty Liver Clinic in the MGH Gastrointestinal Unit. Dr. Corey is also the Associate Director of the MGH Weight Center.

Dr. Corey's clinical interest include all areas of hepatology including non-alcoholic fatty liver disease (NAFLD), viral hepatitis including hepatitis B, C and D infection, autoimmune hepatitis, cholestatic liver disease including primary biliary cirrhosis and primary sclerosing cholangitis. In addition, Dr. Corey treats patients with hereditary forms of liver disease including hemochromatosis and alpha-1-antitrypsin disease. Dr. Corey also performs endoscopies including diagnostic and therapeutic upper endoscopy and colonoscopy.

Dr. Corey's research focuses on non-alcoholic fatty liver disease and the development of non-invasive biomarkers for the diagnosis and monitoring of NAFLD.  Dr. Corey has lectured regionally and nationally on NAFLD.

http://articles.chicagotribune.com/2012-04-18/health/sc-health-0418-fatty-liver-20120418_1_nonalcoholic-fatty-liver-disease-nonalcoholic-steatohepatitis-obese-people

ResearchDr. Corey's research focuses on lipid metabolism in patients with steatosis and steatohepatitis as well as the development of non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease. Dr. Corey also participates in numerous clinical trials including studies for hepatitis B and C treatment and post-transplant prevention of hepatitis C infection.

Publications

View my most recent publications at PubMed

Weight Center restructures

ACCORDING TO RECENT DATA from the National Health and Nutrition Examination Survey, approximately one-third of U.S. adults and 17 percent of children and adolescents aged 2 to 19 years are obese.